Blogs

Prasol Chemicals IPO: Price Band, GMP, IPO Date, Lot Size, Financials & Review

Prasol Chemicals IPO is set to open for subscription on September 8, 2026, giving investors an opportunity to invest in a specialty chemicals manufacturer with a diversified product portfolio and presence across domestic and international markets.

The company has fixed the Prasol Chemicals IPO price band at Rs.643 to Rs.676 per equity share and plans to raise approximately Rs.500 crore through the public issue. The IPO comprises a fresh issue of Rs.80 crore and an Offer for Sale (OFS) of Rs.420 crore.

Prasol Chemicals manufactures more than 150 specialty chemicals used across industries including performance chemicals, paints and inks, construction, adhesives, pharmaceuticals, agrochemicals and home and personal care.

The company's financial performance has also improved significantly, with revenue increasing to approximately Rs.1,237.85 crore in FY26, while PAT rose to Rs.83.12 crore, compared with Rs.43.57 crore in FY25.

However, investors should not look at the profit growth in isolation. The IPO valuation, large OFS component, cyclicality of the chemical industry and the company's ability to sustain margins will be important factors in determining whether the issue is attractive.

Prasol Chemicals IPO – Key Details

Particulars	Details
Company	Prasol Chemicals Limited
Sector	Specialty Chemicals
IPO Type	Mainboard IPO
IPO Open Date	September 8, 2026
IPO Close Date	September 10, 2026
Price Band	Rs.643 – Rs.676
Issue Size	Rs.500 crore
Fresh Issue	Rs.80 crore
Offer for Sale	Rs.420 crore
Face Value	Rs.2 per share
Lot Size	22 shares
Minimum Investment	Rs.14,872
Listing	NSE & BSE
Basis of Allotment	September 11, 2026
Tentative Listing Date	September 16, 2026
Registrar	KFin Technologies
Lead Manager	DAM Capital Advisors

The minimum application size for retail investors is 22 shares. At the upper price band of Rs.676, investors need approximately Rs.14,872 to apply for one lot.

Prasol Chemicals IPO GMP Today

The Prasol Chemicals IPO GMP is currently around Rs.14, according to the latest available grey-market data.

At the upper IPO price of Rs.676, a GMP of Rs.14 indicates an estimated grey-market price of approximately Rs.690.

That translates into an indicative premium of roughly 2.07% over the upper price band.

Particulars	Value
Upper IPO Price	Rs.676
Current GMP	Rs.14
Estimated Listing Price	Rs.690
Indicative Gain	~2.07%

However, investors should be careful with GMP.

Grey Market Premium is unofficial, unregulated and can change rapidly before listing. It should be treated as a sentiment indicator rather than a reliable prediction of the actual listing price. InvestorGain itself cautions that investment decisions based solely on GMP can be risky.

The current GMP of around Rs.14 also suggests that, at least at present, the grey market is not pricing in a major listing pop.

About Prasol Chemicals

Prasol Chemicals is a specialty chemicals manufacturer that develops and produces a broad range of chemical products for multiple industrial applications.

The company manufactures more than 150 specialty chemicals, including:

• Acetone-based chemicals
• Phosphorous-based chemicals
• Surfactants
• Esters
• Acids
• Other complex specialty chemicals

Its products are supplied to customers across several industries, reducing its dependence on any single end-use market.

The company's five major application industries include performance chemicals, paints/inks/construction/adhesives, pharmaceuticals, agrochemicals, and home and personal care.

This diversification is an important strength because demand weakness in one end-use industry may potentially be offset by demand from other sectors.

Prasol Chemicals' Manufacturing Facilities

Prasol Chemicals operates manufacturing facilities in Khopoli and Mahad in Maharashtra.

The facilities collectively cover substantial manufacturing infrastructure, with an aggregate capacity of approximately 87,914 MT per year.

The company has developed capabilities across several specialty chemical categories rather than focusing exclusively on a single product.

This is particularly relevant in specialty chemicals because customers often require consistent quality, technical support and reliable supply rather than simply buying based on the lowest price.

Prasol Chemicals' Customer Base

Prasol Chemicals has built relationships with customers across several industries and geographies.

Its customer base includes names such as:

Key Customers

Alembic Pharmaceuticals

Lubrizol India

Rossari Biotech

Clean Science

Gharda Chemicals

Croda India

Supriya Lifescience

Yasho Industries

As of July 31, 2025, the company served approximately 1,107 customers across 69 countries.

The geographical diversification is another important part of the company's business model.

Prasol Chemicals exports to markets across Asia-Pacific, North America, South America and Europe, and the company has been recognised as a 3 Star Export House by the Government of India.

Prasol Chemicals Business Model

Prasol Chemicals operates in a segment where products are generally sold to industrial customers rather than directly to consumers.

The company's business model can broadly be understood as:

Raw Materials ? Chemical Processing ? Specialty Products ? Industrial Customers ? Domestic & Export Markets

The specialty nature of its products can potentially provide better margins than commoditised chemicals because customers may place greater emphasis on product performance, consistency, technical specifications and reliability.

However, the business remains exposed to fluctuations in raw-material prices, energy costs, foreign exchange movements and broader chemical-cycle conditions.

Prasol Chemicals IPO Financial Performance

The company's financial performance has improved meaningfully over the past three financial years.

Particulars	FY24	FY25	FY26
Total Income	Rs.887.56 Cr	Rs.1,015.54 Cr	Rs.1,237.85 Cr
PAT	Rs.18.13 Cr	Rs.43.57 Cr	Rs.83.12 Cr
EBITDA	Rs.60.53 Cr	Rs.87.77 Cr	Rs.139.32 Cr
Net Worth	Rs.325.84 Cr	Rs.367.46 Cr	Rs.448.51 Cr
Total Borrowings	Rs.82.07 Cr	Rs.101.05 Cr	Rs.110.06 Cr
Total Assets	Rs.626.36 Cr	Rs.723.09 Cr	Rs.839.28 Cr

Figures in Rs. crore.

According to the latest available financial data, revenue increased from Rs.1,015.54 crore in FY25 to Rs.1,237.85 crore in FY26, representing growth of approximately 22%.

PAT increased much faster, from Rs.43.57 crore to Rs.83.12 crore, representing growth of approximately 91%. EBITDA also increased from Rs.87.77 crore to Rs.139.32 crore.

This combination of revenue growth and operating-profit improvement is one of the stronger aspects of the Prasol Chemicals IPO story.

Profitability Analysis

Prasol Chemicals reported an EBITDA margin of 11.30% and PAT margin of 6.74% in FY26.

The company also reported:

Ratio	FY26
ROE	20.37%
ROCE	22.43%
Debt/Equity	0.19
RoNW	18.53%
EBITDA Margin	11.30%
PAT Margin	6.74%

The ROCE of 22.43% is particularly worth watching because Prasol operates a manufacturing business requiring physical assets and working capital.

A ROCE above 20% indicates reasonably efficient utilisation of the capital employed, although investors should check whether this level is sustainable across the chemical cycle.

The debt-to-equity ratio of 0.19 also indicates that the company is not excessively leveraged.

Prasol Chemicals IPO – Use of Funds

This is where investors need to look carefully at the structure of the IPO.

The total issue size is Rs.500 crore, but only Rs.80 crore represents a fresh issue.

The remaining Rs.420 crore is an Offer for Sale.

The net proceeds from the fresh issue are proposed to be used primarily for repayment or prepayment of borrowings.

Purpose	Amount
Repayment/prepayment of borrowings	Rs.60 Cr
General Corporate Purposes	Balance
Total Fresh Issue	Rs.80 Cr

This means Prasol Chemicals is not raising a large amount of fresh capital for aggressive capacity expansion through this IPO.

Instead, the IPO provides a combination of balance-sheet strengthening and an exit opportunity for existing shareholders.

What Does the Large OFS Mean?

The Rs.420 crore OFS represents around 84% of the total IPO size.

This means the majority of the issue proceeds will go to existing selling shareholders rather than directly into the company's bank account.

A large OFS is not automatically a negative signal. Private-equity and early investors often use IPOs as a route to partially monetise their investments.

However, from the perspective of a new investor, it is important to understand that only Rs.80 crore of fresh capital is being raised by the company.

The IPO should therefore not be marketed as a Rs.500 crore growth-capital raise.

Prasol Chemicals IPO Valuation

Valuation is one of the most important areas to examine before applying.

Prasol Chemicals has reported FY26 diluted EPS of approximately Rs.14.33.

At the IPO price band:

At Rs.643:

P/E ˜ 44.8×

At Rs.676:

P/E ˜ 47.2×

This means investors are being asked to pay approximately 45–47 times FY26 earnings.

That is not a cheap valuation.

However, the specialty chemical sector itself can command premium valuations depending on growth, return ratios, product complexity, customer relationships and earnings visibility.

Prasol's valuation needs to be compared with its listed peers.

Prasol Chemicals vs Peers

Company	P/E	RoNW
Excel Industries	17.12×	4.44%
Yasho Industries	206.68×	5.69%
Privi Speciality Chemicals	42.67×	21.99%
Vinati Organics	30.95×	14.03%
Laxmi Organic Industries	59.74×	4.00%
Atul	28.04×	10.95%
Aarti Industries	46.75×	7.04%
Prasol Chemicals	~47.2×	18.53%

The peer comparison provides a mixed picture.

Prasol is more expensive than companies such as Excel Industries, Vinati Organics and Atul on a P/E basis, while its valuation is broadly around Aarti Industries and below some higher-valued specialty chemical companies.

At the same time, Prasol's 18.53% RoNW is comparatively healthy.

Therefore, the valuation cannot simply be called cheap, but it is also not completely disconnected from the company's profitability profile.

Key Strengths of Prasol Chemicals IPO

Diversified Product Portfolio

The company manufactures more than 150 specialty chemicals and serves multiple end-use industries.

This reduces dependence on any single product or sector.

Strong Financial Growth

Revenue has grown consistently, while PAT has increased substantially over the last three years.

Healthy Return Ratios

ROE of 20.37% and ROCE of 22.43% indicate reasonably strong capital efficiency.

Low Leverage

A debt-to-equity ratio of 0.19 provides a relatively comfortable balance-sheet position.

Global Presence

Prasol serves customers across 69 countries and has an established export network.

Diversified Customer Base

More than 1,100 customers across different industries and geographies provide diversification.

Specialty Chemical Exposure

Specialty chemicals can offer better customer stickiness and margins compared with highly commoditised chemical products, provided the company maintains product quality and technological capabilities.

Risks of Prasol Chemicals IPO

Expensive Valuation

At roughly 47× FY26 earnings at the upper price band, the IPO is not cheap.

The company will need to maintain strong earnings growth to justify this valuation.

Large OFS

Rs.420 crore of the Rs.500 crore issue is an OFS.

Only Rs.80 crore represents fresh capital for the company.

Raw Material Price Volatility

Chemical manufacturers are exposed to fluctuations in raw-material and energy prices.

If the company cannot pass cost increases to customers, margins could come under pressure.

Cyclical Industry

Specialty chemicals can experience periods of strong demand followed by inventory corrections and pricing pressure.

Export Exposure

With customers across international markets, the company is exposed to currency fluctuations, global economic conditions, geopolitical developments and trade policies.

Customer Concentration Risk

Although the overall customer base is diversified, the loss or reduction in business from important customers could still affect individual product segments.

Execution Risk

Maintaining growth requires continued R&D, new-product development, capacity utilisation and successful expansion into new markets.

Prasol Chemicals IPO GMP vs Fundamentals

The current GMP of around Rs.14 implies only a modest premium of approximately 2% over the upper issue price.

That is not particularly exciting for a mainboard IPO.

But the more important question is whether an investor should buy Prasol Chemicals at the IPO valuation for the next three to five years.

The answer depends on whether the company can sustain:

20%+ revenue growth + margin expansion + healthy ROCE + controlled debt.

If earnings continue growing rapidly, today's valuation could eventually look reasonable.

If earnings growth slows materially, a P/E of around 47× leaves relatively little room for error.

Prasol Chemicals IPO – Should You Apply?

Prasol Chemicals has several characteristics that make it an interesting company.

It has a diversified product portfolio, an international customer base, improving profitability, healthy return ratios and relatively low leverage.

The financial trend is particularly encouraging.

However, the IPO price is not cheap.

At approximately 47× FY26 earnings at the upper band, investors are already paying a significant premium for the company's growth potential.

The current GMP of around Rs.14 also does not indicate strong expectations for listing gains.

Therefore, investors need to distinguish between a good company and a good IPO price.

Prasol Chemicals appears to be a reasonably strong specialty-chemical business, but the IPO valuation demands continued earnings growth.

Our Prasol Chemicals IPO Review

Factor	View
Business Quality	Positive
Revenue Growth	Positive
Profit Growth	Positive
Profitability	Positive
Debt	Positive
Product Diversification	Positive
Global Presence	Positive
Valuation	Expensive
OFS Component	Negative
Current GMP	Mildly Positive
Long-Term Potential	Positive
Overall IPO View	Moderately Positive

Final Verdict

Prasol Chemicals IPO Rating: 3.5/5

Our View: Apply selectively for the long term, but don't chase it purely for listing gains.

Prasol Chemicals offers exposure to a diversified specialty chemicals business with strong recent financial improvement. Revenue, EBITDA and PAT have all grown significantly, while the company maintains a relatively low debt-to-equity ratio and healthy return ratios.

The biggest concern is valuation.

At nearly 47× FY26 earnings, the IPO already prices in a meaningful amount of future growth. The 84% OFS component is another factor investors should understand before applying.

For investors looking for a short-term listing gain, the current GMP of around Rs.14 does not provide a particularly compelling risk-reward profile.

For long-term investors, however, the company deserves consideration if they are comfortable paying a premium for a specialty chemicals business with improving earnings and strong return ratios.

The key factor to monitor after listing will be whether Prasol can continue growing earnings at a rate sufficient to support its premium valuation.

Prasol Chemicals IPO Important Dates

Event	Date
IPO Opens	September 8, 2026
IPO Closes	September 10, 2026
Basis of Allotment	September 11, 2026
Refunds	September 15, 2026
Shares Credited	September 15, 2026
Listing Date	September 16, 2026

The dates are tentative and may be subject to change.

Frequently Asked Questions

What is the Prasol Chemicals IPO price band?

The price band has been fixed at Rs.643 to Rs.676 per share.

What is the Prasol Chemicals IPO issue size?

The total issue size is Rs.500 crore, consisting of Rs.80 crore fresh issue and Rs.420 crore OFS.

What is the Prasol Chemicals IPO lot size?

The minimum lot size is 22 shares.

What is the minimum investment required?

At the upper price band of Rs.676, one lot requires an investment of approximately Rs.14,872.

What is the Prasol Chemicals IPO GMP today?

The latest available GMP is around Rs.14, implying an indicative listing price of approximately Rs.690. GMP is unofficial and can change before listing.

Is Prasol Chemicals IPO good for listing gains?

At the current GMP, the expected premium is modest. Therefore, the IPO does not currently appear particularly attractive purely from a listing-gain perspective.

Is Prasol Chemicals good for long-term investment?

The company has strong recent financial growth, healthy return ratios, diversified products and relatively low leverage. However, the valuation is demanding. Long-term investors should therefore consider the IPO based on their risk tolerance and expectations for future earnings growth.

What does Prasol Chemicals manufacture?

The company manufactures more than 150 specialty chemicals, including acetone-based and phosphorous-based chemicals, surfactants, esters, acids and other specialty products.

Where does Prasol Chemicals operate?

The company has manufacturing facilities in Khopoli and Mahad, Maharashtra, with an aggregate capacity of approximately 87,914 MT per year.

Who is the registrar of Prasol Chemicals IPO?

KFin Technologies is the registrar to the Prasol Chemicals IPO.

Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice. IPO investments are subject to market risks. Investors should carefully read the company's RHP and other offer documents before making an investment decision.